Department of Respiratory and Critical Care Medicine, Xiang Yang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Thorac Cancer. 2023 Feb;14(6):544-554. doi: 10.1111/1759-7714.14777. Epub 2022 Dec 27.
The study aimed to explore the effect of circ_0008003 on the progression of non-small-cell lung cancer (NSCLC) and its underlying regulation mechanism.
Expression of hsa_circ_0008003, miRNA (miR)-548I and karyopherin subunit α 4 (KPNA4) was examined by quantitative real-time polymerase chain reaction. Cell viability and proliferation ability were detected by cell counting kit-8 assay and 5-ethynyl-2'-deoxyuridine assay, respectively. Flow cytometry was performed to monitor cell apoptosis. Western blot assay was used to evaluate the protein levels of KPNA4, Bax, and Bcl-2. Cell migration and invasion were assessed by transwell assays. The targeted relationship between miR-548I and hsa_circ_0008003 or KPNA4 was confirmed by dual-luciferase reporter and RNA immunoprecipitation assays. Furthermore, the role of hsa_circ_0008003 in vivo was investigated by xenograft assay.
Circ_0008003 expression was increased in NSCLC tissues and cell lines. Circ_0008003 knockdown reduced cell viability, migration, invasion, angiogenesis, and caused apoptosis in NSCLC cells. Moreover, miR-548I was targeted by circ_0008003, and miR-548I knockdown reversed the influence of circ_0008003 silence on NSCLC progression. KPNA4 was targeted by miR-548I, and miR-548I overexpression suppressed cell viability, migration, invasion, angiogenesis, and promoted cell apoptosis via decreasing KPNA4. In addition, circ_0008003 regulated KPNA4 expression via miR-548I. Circ_0008003 knockdown decreased NSCLC cell growth in the xenograft model.
Circular RNA hsa_circ_0008003 promoted progression in NSCLC by sponging miR-548I and regulating KPNA4 expression, hinting that circ_0008003 participates in NSCLC pathogenesis.
本研究旨在探讨环状 RNA(circRNA)circ_0008003 对非小细胞肺癌(NSCLC)进展的影响及其潜在的调控机制。
采用实时定量聚合酶链反应(qRT-PCR)检测 hsa_circ_0008003、微小 RNA(miRNA)miR-548I 和核孔蛋白亚基α4(KPNA4)的表达。通过细胞计数试剂盒-8(CCK-8)检测细胞活力和增殖能力,通过 5-乙炔基-2'-脱氧尿苷(EdU)检测细胞增殖能力,通过流式细胞术监测细胞凋亡,通过 Western blot 检测 KPNA4、Bax 和 Bcl-2 蛋白水平。通过 Transwell 检测细胞迁移和侵袭。采用双荧光素酶报告基因和 RNA 免疫沉淀(RIP)实验验证 miR-548I 与 hsa_circ_0008003 或 KPNA4 的靶向关系。通过异种移植实验研究 hsa_circ_0008003 的体内作用。
circ_0008003 在 NSCLC 组织和细胞系中表达上调。circ_0008003 敲低可降低 NSCLC 细胞活力、迁移、侵袭和血管生成,并诱导细胞凋亡。此外,circ_0008003 可靶向结合 miR-548I,并且 miR-548I 敲低可逆转 circ_0008003 沉默对 NSCLC 进展的影响。miR-548I 可靶向结合 KPNA4,过表达 miR-548I 可通过降低 KPNA4 抑制细胞活力、迁移、侵袭和血管生成,并促进细胞凋亡。此外,circ_0008003 通过 miR-548I 调节 KPNA4 的表达。circ_0008003 敲低可抑制异种移植模型中 NSCLC 细胞的生长。
circRNA hsa_circ_0008003 通过海绵吸附 miR-548I 并调节 KPNA4 的表达促进 NSCLC 的进展,提示 circ_0008003 参与 NSCLC 的发病机制。